美股医药股整体表现 - 美股医药股在10月1日逆势上涨 [1] 主要公司股价涨幅 - 阿斯利康股价上涨超过6% [1] - 赛诺菲安万特和葛兰素史克股价均上涨接近4% [1] - 礼来、渤健公司、诺和诺德、默沙东股价均上涨接近3% [1] - 辉瑞股价上涨超过2% [1]

美股医药股整体表现 - 医药股在美股市场整体逆势上涨 [1] 主要公司股价表现 - 阿斯利康股价上涨超过6% [1] - 赛诺菲安万特股价上涨接近4% [1] - 葛兰素史克股价上涨接近4% [1] - 礼来公司股价上涨接近3% [1] - 渤健公司股价上涨接近3% [1] - 诺和诺德股价上涨接近3% [1] - 默沙东股价上涨接近3% [1] - 辉瑞公司股价上涨超过2% [1]

WASHINGTON, DC - SEPTEMBER 30: Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump as Centers for Medicare & Medicaid Services Mehmet Oz looks on after Trump announced a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. (Photo by Win McNamee/Getty Images)Getty ImagesPfizer stock (NYSE: PFE) offers a compelling investment opportunity at its current price of around $25, supported by attractive valuations and ...

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC.President Donald Trump's long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer.Trump's Tuesday agreement with the company to voluntarily lower U.S. drug prices included a three-year ex ...

President Trump announcing a deal with Fizer. The drug maker will be selling medication directly to consumers through a new website that's called Trump RX. The company won't face Pharma specific tariffs as long as it invests in US manufacturing.Joining us right now is John Lamatina. He is a senior partner at Pure Tech Health and he's also the author of multiple books on the industry including Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices. He's also the former president of Fizer Global ...

行业趋势 - 瑞士制药公司可能效仿辉瑞与美国达成的药品定价协议 [1] - 此趋势源于特朗普政府要求降低药品价格的压力 [1]

(Reuters) -Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration moves ahead with a 100% tariff on imported branded and patented drugs, starting October 1. The sweeping measure has triggered a flurry of activity across the industry, including fast-tracking U.S. manufacturing projects, price cuts and direct-to-consumer sales. Here's what drugmakers are doing to mitigate supply-chain risks and reassure investors: Pfizer Pfizer re ...

外汇市场分析覆盖范围 - 分析涵盖欧元兑美元汇率 [1] - 分析涵盖美元兑日元汇率 [1] - 分析涵盖美元兑瑞士法郎汇率 [1] - 分析涵盖欧元兑瑞士法郎汇率 [1]

Three supercharged income stocks have the catalysts necessary to pad the pocketbooks of patient investors.For more than a century, the stock market has reigned supreme as the most-decorated wealth creator. No asset class has come close to matching the average annual return of stocks -- and with thousands of publicly traded companies to choose from, there's likely one or more securities that can help you reach your investment goals.But among the countless ways to grow your wealth, buying and holding high-qua ...

事件概述 - 欧洲医疗保健股在周三出现上涨 [1] 事件背景 - 事件发生的前一日 辉瑞公司与美国总统唐纳德·特朗普表示 这家美国制药商同意降低医疗补助计划中的处方药价格 [1] - 作为交换条件 辉瑞公司将获得关税减免 [1]